tetrachloroisophthalonitrile and Coronary Artery Disease

tetrachloroisophthalonitrile has been researched along with Coronary Artery Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Anthopoulos, P; Cao, D; Chen, S; Dangas, G; Dumonteil, N; Feldman, D; Ferrari, M; Hengstenberg, C; Jeger, R; Mehran, R; Meneveau, N; Nicolas, J; Razuk, V; Sartori, S; Spirito, A; Stella, PR; Tron, C; Violini, R; Vogel, B; Widder, JD; Yan, R; Zhang, Z	1

Trials

1 trial(s) available for tetrachloroisophthalonitrile and Coronary Artery Disease

Article	Year
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2023, Volume: 101, Issue:6 Topics: Antithrombins; Coronary Artery Disease; Hemorrhage; Heparin; Hirudins; Humans; Peptide Fragments; Recombinant Proteins; Transcatheter Aortic Valve Replacement; Treatment Outcome	2023

Article

Year

Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2023, Volume: 101, Issue:6

Topics: Antithrombins; Coronary Artery Disease; Hemorrhage; Heparin; Hirudins; Humans; Peptide Fragments; Recombinant Proteins; Transcatheter Aortic Valve Replacement; Treatment Outcome

2023